litlas
Log inCreate account

Guido Dalbagni

Active 1992–2025

97
Papers
19,482
Citations
77
h-index
96
i10-index

Citations

Citations per year for Guido Dalbagni1956: 1 citations1992: 1 citations1993: 5 citations1994: 23 citations1995: 47 citations1996: 23 citations1997: 29 citations1998: 30 citations1999: 45 citations2000: 37 citations2001: 31 citations2002: 39 citations2003: 53 citations2004: 47 citations2005: 62 citations2006: 64 citations2007: 82 citations2008: 72 citations2009: 90 citations2010: 94 citations2011: 128 citations2012: 120 citations2013: 132 citations2014: 102 citations2015: 77 citations2016: 100 citations2017: 84 citations2018: 115 citations2019: 463 citations2020: 554 citations2021: 381 citations2022: 272 citations2023: 223 citations2024: 370 citations2025: 150 citations2026: 6 citations1957–1991: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,568 citing papers, 24.6% of this breakdownItaly: 464 citing papers, 7.3% of this breakdownChina: 441 citing papers, 6.9% of this breakdownGermany: 390 citing papers, 6.1% of this breakdownUnited Kingdom: 319 citing papers, 5% of this breakdownFrance: 295 citing papers, 4.6% of this breakdownCanada: 290 citing papers, 4.5% of this breakdownSpain: 245 citing papers, 3.8% of this breakdownAustria: 240 citing papers, 3.8% of this breakdownNetherlands: 238 citing papers, 3.7% of this breakdownJapan: 237 citing papers, 3.7% of this breakdownSwitzerland: 147 citing papers, 2.3% of this breakdown
0%24.6%Other 23.7%

Institutions

Fields

  • Medicine85.2%
  • Biochemistry, Genetics and Molecular Biology11.5%
  • Computer Science0.9%
  • Immunology and Microbiology0.6%
  • Engineering0.4%
  • Environmental Science0.3%
  • Other1.1%

Topics

  • Bladder and Urothelial Cancer Treatments24.4%
  • Urinary and Genital Oncology Studies14.8%
  • Urinary Tract Infections Management2.6%
  • Urological Disorders and Treatments2.6%
  • Renal cell carcinoma treatment2.5%
  • Epigenetics and DNA Methylation2.5%
  • Other50.6%

Coauthors

All papers

Open in search
  1. Epidemiology and Risk Factors of Urothelial Bladder Cancer

    Authors: Maximilian Burger, James W.F. Catto, Guido Dalbagni, H. Barton Grossman, Harry W. Herr, Pierre I. Karakiewicz, Wassim Kassouf, Lambertus A. Kiemeney, Carlo La Vecchia, Shahrokh F. Shariat, Yair Lotan - European Urology 2012 cited by 2,187

  2. Next-generation Sequencing of Nonmuscle Invasive Bladder Cancer Reveals Potential Biomarkers and Rational Therapeutic Targets

    Authors: Eugene J. Pietzak, Aditya Bagrodia, Eugene K. Cha, Esther Drill, Gopa Iyer, Sumit Isharwal, Irina Ostrovnaya, Priscilla Baez, Qiang Li, Michael F. Berger, Ahmet Zehir, Nikolaus Schultz, Jonathan E. Rosenberg, Dean F. Bajorin, Guido Dalbagni, Hikmat Al‐Ahmadie, David B. Solit, Bernard H. Bochner - European Urology 2017 cited by 372

  3. Defining Early Morbidity of Radical Cystectomy for Patients with Bladder Cancer Using a Standardized Reporting Methodology

    Authors: Ahmad Shabsigh, Ruslan Korets, Kinjal Vora, Christine Brooks, Angel M. Cronin, Caroline Savage, Ganesh V. Raj, Bernard H. Bochner, Guido Dalbagni, Harry W. Herr, S. Machele Donat - European Urology 2008 cited by 1,399

  4. Multicenter Phase II Clinical Trial of Gemcitabine and Cisplatin as Neoadjuvant Chemotherapy for Patients With High-Grade Upper Tract Urothelial Carcinoma

    Authors: Jonathan Coleman, Wesley Yip, Nathan C. Wong, Daniel D. Sjoberg, Bernard H. Bochner, Guido Dalbagni, S. Machele Donat, Harry W. Herr, K. Eugene, Timothy F. Donahue, Eugene J. Pietzak, A. Ari Hakimi, Kwanghee Kim, Hikmat Al‐Ahmadie, H. Alberto Vargas, Ricardo Alvim, Soleen Ghafoor, Nicole Benfante, Anoop Meraney, Steven J. Shichman, Jeffrey M. Kamradt, Suresh Nair, Angelo A. Baccala, Paul Palyca, Bradley W. Lash, Muhammad A. Rizvi, Scott K. Swanson, Antonio F Muina, Andrea B. Apolo, Gopa Iyer, Jonathan E. Rosenberg, Min Yuen Teo, Dean F. Bajorin - Journal of Clinical Oncology 2023 cited by 105

  5. Age‐adjusted Charlson comorbidity score is associated with treatment decisions and clinical outcomes for patients undergoing radical cystectomy for bladder cancer

    Authors: Theresa M. Koppie, Angel M. Serio, Andrew J. Vickers, Kinjal Vora, Guido Dalbagni, S. Machele Donat, Harry W. Herr, Bernard H. Bochner - Cancer 2008 cited by 357

  6. Health-related Quality of Life for Patients Undergoing Radical Cystectomy: Results of a Large Prospective Cohort

    Authors: Matthew Clements, Thomas M. Atkinson, Guido Dalbagni, Yuelin Li, Andrew J. Vickers, Harry W. Herr, S. Machele Donat, Jaspreet S. Sandhu, Daniel Sjöberg, Amy L. Tin, Bruce D. Rapkin, Bernard H. Bochner - European Urology 2021 cited by 102

  7. Impact of renal impairment on eligibility for adjuvant cisplatin‐based chemotherapy in patients with urothelial carcinoma of the bladder

    Authors: Atreya Dash, Matthew D. Galsky, Andrew J. Vickers, Angel M. Serio, Theresa M. Koppie, Guido Dalbagni, Bernard H. Bochner - Cancer 2006 cited by 433

  8. Clonal Relatedness and Mutational Differences between Upper Tract and Bladder Urothelial Carcinoma

    Authors: François Audenet, Sumit Isharwal, Eugene K. Cha, Mark T.A. Donoghue, Esther Drill, Irina Ostrovnaya, Eugene J. Pietzak, John P. Sfakianos, Aditya Bagrodia, Paari Murugan, Guido Dalbagni, Timothy F. Donahue, Jonathan E. Rosenberg, Dean F. Bajorin, Maria E. Arcila, Jaclyn F. Hechtman, Michael F. Berger, Barry S. Taylor, Hikmat Al‐Ahmadie, Gopa Iyer, Bernard H. Bochner, Jonathan Coleman, David B. Solit - Clinical Cancer Research 2018 cited by 283

  9. Comparing Open Radical Cystectomy and Robot-assisted Laparoscopic Radical Cystectomy: A Randomized Clinical Trial

    Authors: Bernard H. Bochner, Guido Dalbagni, Daniel D. Sjoberg, Jonathan Silberstein, Gal E. Keren Paz, S. Machele Donat, Jonathan Coleman, Sheila Mathew, Andrew J. Vickers, Geoffrey Schnorr, Michael Feuerstein, Bruce D. Rapkin, Raul O. Parra, Harry W. Herr, Vincent P. Laudone - European Urology 2014 cited by 597

  10. Genomic Characterization of Upper Tract Urothelial Carcinoma

    Authors: John P. Sfakianos, Eugene K. Cha, Gopa Iyer, Sasinya N. Scott, Emily C. Zabor, Ronak Shah, Qinghu Ren, Aditya Bagrodia, Philip H. Kim, A. Ari Hakimi, Irina Ostrovnaya, Ricardo J. Ramirez, Aphrothiti J. Hanrahan, Neil Desai, Arony Sun, Patrizia Pinciroli, Jonathan E. Rosenberg, Guido Dalbagni, Nikolaus Schultz, Dean F. Bajorin, Victor E. Reuter, Michael F. Berger, Bernard H. Bochner, Hikmat Al‐Ahmadie, David B. Solit, Jonathan Coleman - European Urology 2015 cited by 277

  11. Changes in Renal Function Following Nephroureterectomy May Affect the Use of Perioperative Chemotherapy

    Authors: Matthew Kaag, Rebecca L. O’Malley, Padraic O’Malley, Guilherme Godoy, Mang Chen, Marc C. Smaldone, Ronald L. Hrebinko, Jay D. Raman, Bernard H. Bochner, Guido Dalbagni, Michael Stifelman, Samir S. Taneja, William C. Huang - European Urology 2010 cited by 292

  12. Frequent somatic CDH1 loss-of-function mutations in plasmacytoid variant bladder cancer

    Authors: Hikmat Al‐Ahmadie, Gopa Iyer, Byron Lee, Sasinya N. Scott, Rohit Mehra, Aditya Bagrodia, Emmet Jordan, Sizhi Paul Gao, Ricardo J. Ramirez, K. Eugene, Neil Desai, Emily C. Zabor, Irina Ostrovnaya, Anuradha Gopalan, Ying‐Bei Chen, Samson W. Fine, Satish K. Tickoo, Anupama Gandhi, Joseph Hreiki, Agnès Viale, Maria E. Arcila, Guido Dalbagni, Jonathan E. Rosenberg, Bernard H. Bochner, Dean F. Bajorin, Michael F. Berger, Victor E. Reuter, Barry S. Taylor, David B. Solit - Nature Genetics 2016 cited by 198

  13. Randomized Trial Comparing Open Radical Cystectomy and Robot-assisted Laparoscopic Radical Cystectomy: Oncologic Outcomes

    Authors: Bernard H. Bochner, Guido Dalbagni, Karim Marzouk, Daniel D. Sjoberg, Justin Lee, Sheri M. Donat, Jonathan Coleman, Andrew J. Vickers, Harry W. Herr, Vincent P. Laudone - European Urology 2018 cited by 267

  14. Urinary diversion after radical cystectomy for bladder cancer: options, patient selection, and outcomes

    Authors: Richard K. Lee, Hassan Abol‐Enein, Walter Artibani, Bernard H. Bochner, Guido Dalbagni, Siamak Daneshmand, Yves Fradet, Richard E. Hautmann, Cheryl T. Lee, Seth P. Lerner, Armin Pycha, Karl‐Dietrich Sievert, Arnulf Stenzl, G.N. Thalmann, Shahrokh F. Shariat - British Journal of Urology 2013 cited by 360

  15. Genomic Differences Between “Primary” and “Secondary” Muscle-invasive Bladder Cancer as a Basis for Disparate Outcomes to Cisplatin-based Neoadjuvant Chemotherapy

    Authors: Eugene J. Pietzak, Emily C. Zabor, Aditya Bagrodia, Joshua Armenia, Wenhuo Hu, Ahmet Zehir, Samuel A. Funt, François Audenet, David Barron, Noelia Maamouri, Qiang Li, Min Yuen Teo, Maria E. Arcila, Michael F. Berger, Nikolaus Schultz, Guido Dalbagni, Harry W. Herr, Dean F. Bajorin, Jonathan E. Rosenberg, Hikmat Al‐Ahmadie, Bernard H. Bochner, David B. Solit, Gopa Iyer - European Urology 2018 cited by 152

  16. Risk Factors for the Development of Parastomal Hernia after Radical Cystectomy

    Authors: Timothy F. Donahue, Bernard H. Bochner, John P. Sfakianos, Matthew Kent, Melanie Bernstein, W. Mark Hilton, Eugene K. Cha, Alyssa Yee, Guido Dalbagni, Hebert Alberto Vargas - The Journal of Urology 2014 cited by 92

  17. PD-L1 Expression in Urothelial Carcinoma With Predominant or Pure Variant Histology

    Authors: Henning Reis, Rene Serrette, Jennifer Posada, Vincent Lu, Ying‐Bei Chen, Anuradha Gopalan, Samson W. Fine, Satish K. Tickoo, S. Joseph Sirintrapun, Gopa Iyer, Samuel A. Funt, Min Yuen Teo, Jonathan E. Rosenberg, Dean F. Bajorin, Guido Dalbagni, Bernard H. Bochner, David B. Solit, Victor E. Reuter, Hikmat Al‐Ahmadie - The American Journal of Surgical Pathology 2019 cited by 88

  18. Guideline for the Management of Nonmuscle Invasive Bladder Cancer (Stages Ta, T1, and Tis): 2007 Update

    Authors: M. Craig Hall, Sam S. Chang, Guido Dalbagni, Raj S. Pruthi, John D. Seigne, Eila C. Skinner, J. Stuart Wolf, Paul F. Schellhammer - The Journal of Urology 2007 cited by 839

  19. Potential Impact of Postoperative Early Complications on the Timing of Adjuvant Chemotherapy in Patients Undergoing Radical Cystectomy: A High-Volume Tertiary Cancer Center Experience

    Authors: S. Machele Donat, Ahmad Shabsigh, Caroline Savage, Angel M. Cronin, Bernard H. Bochner, Guido Dalbagni, Harry W. Herr, Matthew I. Milowsky - European Urology 2008 cited by 260

  20. Cancer Susceptibility Mutations in Patients With Urothelial Malignancies

    Authors: Maria I. Carlo, Vignesh Ravichandran, Preethi Srinavasan, Chaitanya Bandlamudi, Yelena Kemel, Ozge Ceyhan‐Birsoy, Semanti Mukherjee, Diana Mandelker, Joshua Chaim, Andrea Knežević, Satshil Rana, Zarina Fnu, Kelsey Breen, Angela G. Arnold, Aliya Khurram, Kaitlyn Tkachuk, C Cipolla, Ashley Marie Regazzi, A. Ari Hakimi, Hikmat Al‐Ahmadie, Guido Dalbagni, Karen A. Cadoo, Michael F. Walsh, Min-Yuen Teo, Samuel A. Funt, Jonathan Coleman, Bernard H. Bochner, Gopa Iyer, David B. Solit, Zsofia K. Stadler, Liying Zhang, Jonathan E. Rosenberg, Barry S. Taylor, Mark E. Robson, Michael F. Berger, Joseph Vijai, Dean F. Bajorin, Kenneth Offit - Journal of Clinical Oncology 2019 cited by 144

  21. Multicenter Prospective Phase II Trial of Neoadjuvant Dose-Dense Gemcitabine Plus Cisplatin in Patients With Muscle-Invasive Bladder Cancer

    Authors: Gopa Iyer, Arjun Vasant Balar, Matthew I. Milowsky, Bernard H. Bochner, Guido Dalbagni, S. Machele Donat, Harry W. Herr, William C. Huang, Samir S. Taneja, Michael Woods, Irina Ostrovnaya, Hikmat Al‐Ahmadie, Maria E. Arcila, Jamie C. Riches, Andreas Meier, Caitlin Bourque, Maha Shady, Helen Won, Tracy L. Rose, William Y. Kim, Brooke Kania, Mariel Elena Boyd, C Cipolla, Ashley Marie Regazzi, Daniela Delbeau, Asia S. McCoy, Hebert Alberto Vargas, Michael F. Berger, David B. Solit, Jonathan E. Rosenberg, Dean F. Bajorin - Journal of Clinical Oncology 2018 cited by 143

  22. The Genitourinary Pathology Society Update on Classification of Variant Histologies, T1 Substaging, Molecular Taxonomy, and Immunotherapy and PD-L1 Testing Implications of Urothelial Cancers

    Authors: Éva Compérat, Mahul B. Amin, Jonathan I. Epstein, Donna E. Hansel, Gladell P. Paner, Hikmat Al‐Ahmadie, Larry True, Dilek Bayder, Trinity J. Bivalacqua, Fadi Brimo, Liang Cheng, John C. Cheville, Guido Dalbagni, Sara M. Falzarano, Jennifer Gordetsky, Charles C. Guo, Sounak Gupta, Ondřej Hes, Gopa Iyer, Seema Kaushal, Lakshmi P. Kunju, Cristina Magi‐Galluzzi, Andrés Matoso, Jesse K. McKenney, George J. Netto, Adeboye O. Osunkoya, Chin Pan, Kristina Pivovarcikova, Maria Rosaria Raspollini, Henning Reis, Jonathan E. Rosenberg, Morgan Rouprêt, Rajal B. Shah, Shahrokh F. Shariat, Kiril Trpkov, Veronika Weyerer, Ming Zhou, Victor Reuter - Advances in Anatomic Pathology 2021 cited by 55

  23. Long-term Outcomes of Local and Metastatic Small Cell Carcinoma of the Urinary Bladder and Genomic Analysis of Patients Treated With Neoadjuvant Chemotherapy

    Authors: Min Yuen Teo, Brendan J. Guercio, Arshi Arora, Xueli Hao, Ashley Marie Regazzi, Timothy F. Donahue, Harry W. Herr, Alvin C. Goh, Eugene K. Cha, Eugene J. Pietzak, Sherri M. Donat, Guido Dalbagni, Bernard H. Bochner, Semra Olgac, Judy Sarungbam, S. Joseph Sirintrapun, Ying‐Bei Chen, Anuradha Gopalan, Samson W. Fine, Satish K. Tickoo, Victor E. Reuter, Britta Weigelt, Anne M. Schultheis, Samuel A. Funt, Dean F. Bajorin, David B. Solit, Gopa Iyer, Irina Ostrovnaya, Jonathan E. Rosenberg, Hikmat Al‐Ahmadie - Clinical Genitourinary Cancer 2022 cited by 33

  24. A role for neoadjuvant gemcitabine plus cisplatin in muscle‐invasive urothelial carcinoma of the bladder

    Authors: Atreya Dash, Joseph A. Pettus, Harry W. Herr, Bernard H. Bochner, Guido Dalbagni, S. Machele Donat, Paul Russo, Mary G. Boyle, Matthew I. Milowsky, Dean F. Bajorin - Cancer 2008 cited by 255